Skip to main content
Erschienen in: Lung 3/2021

13.05.2021 | ASTHMA

The Association Between Asthma and Risk of Myasthenia Gravis: A Systematic Review and Meta-analysis

verfasst von: Pitchaporn Yingchoncharoen, Nipith Charoenngam, Ben Ponvilawan, Jerapas Thongpiya, Thanat Chaikijurajai, Patompong Ungprasert

Erschienen in: Lung | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to investigate the association between asthma and risk of myasthenia gravis (MG) using the method of systematic review and meta-analysis.

Methods

Potentially eligible studies were identified from Medline and EMBASE databases from inception to July 2020 using search strategy that comprised terms for “Asthma” and “Myasthenia Gravis”. Eligible cohort study must consist of one cohort of individuals with asthma and another cohort of individuals without asthma. Then, the study must report relative risk (RR) with 95% confidence intervals (95% CIs) of incident MG between the groups. Eligible case–control studies must include cases with MG and controls without MG. Then, the study must explore their history of asthma. Odds ratio (OR) with 95% CIs of the association between asthma status and MG must be reported. Point estimates with standard errors were retrieved from each study and were combined together using the generic inverse variance method.

Results

A total of 6,835 articles were identified. After two rounds of independent review by five investigators, two cohort studies and three case–control studies met the eligibility criteria and were included into the meta-analysis. Pooled analysis showed that asthma was significantly associated with risk of MG with the pooled risk ratio of 1.38 (95% CI 1.02–1.86). Funnel plot was symmetric, which was not suggestive of publication bias.

Conclusion

The current study found a significant association between asthma and increased risk of MG.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023–1036CrossRef Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023–1036CrossRef
3.
Zurück zum Zitat Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8(5):427–438CrossRef Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8(5):427–438CrossRef
4.
Zurück zum Zitat Hehir MK, Silvestri NJ (2018) Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin 36(2):253–260CrossRef Hehir MK, Silvestri NJ (2018) Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin 36(2):253–260CrossRef
5.
Zurück zum Zitat Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100CrossRef Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100CrossRef
6.
Zurück zum Zitat Mims JW (2015) Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol 5(Suppl 1):S2–6CrossRef Mims JW (2015) Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol 5(Suppl 1):S2–6CrossRef
7.
Zurück zum Zitat Maddox L, Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53(1):477–498CrossRef Maddox L, Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53(1):477–498CrossRef
8.
Zurück zum Zitat Croisant S (2014) Epidemiology of asthma: prevalence and burden of disease. Heterogeneity in asthma. Springer, Boston, pp 17–29CrossRef Croisant S (2014) Epidemiology of asthma: prevalence and burden of disease. Heterogeneity in asthma. Springer, Boston, pp 17–29CrossRef
9.
Zurück zum Zitat Sze E, Bhalla A, Nair P (2020) Mechanisms and therapeutic strategies for non-T2 asthma. Allergy 75(2):311–325CrossRef Sze E, Bhalla A, Nair P (2020) Mechanisms and therapeutic strategies for non-T2 asthma. Allergy 75(2):311–325CrossRef
10.
Zurück zum Zitat Charoenngam N et al (2021) Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol 40(2):529–536CrossRef Charoenngam N et al (2021) Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol 40(2):529–536CrossRef
11.
Zurück zum Zitat Shen T-C et al (2016) Risk of asthma in patients with primary Sjögren’s syndrome: a retrospective cohort study. BMC Pulm Med 16(1):152–152CrossRef Shen T-C et al (2016) Risk of asthma in patients with primary Sjögren’s syndrome: a retrospective cohort study. BMC Pulm Med 16(1):152–152CrossRef
12.
Zurück zum Zitat Charoenngam N et al (2020) Patients with asthma have a higher risk of rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(5):968–976CrossRef Charoenngam N et al (2020) Patients with asthma have a higher risk of rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(5):968–976CrossRef
13.
Zurück zum Zitat Hsiao YP et al (2014) Atopic diseases and systemic lupus erythematosus: an epidemiological study of the risks and correlations. Int J Environ Res Public Health 11(8):8112–8122CrossRef Hsiao YP et al (2014) Atopic diseases and systemic lupus erythematosus: an epidemiological study of the risks and correlations. Int J Environ Res Public Health 11(8):8112–8122CrossRef
14.
Zurück zum Zitat Jeong HE, Jung SM, Cho SI (2018) Association between rheumatoid arthritis and respiratory allergic diseases in Korean adults: a propensity score matched case-control study. Int J Rheumatol 2018:3798124CrossRef Jeong HE, Jung SM, Cho SI (2018) Association between rheumatoid arthritis and respiratory allergic diseases in Korean adults: a propensity score matched case-control study. Int J Rheumatol 2018:3798124CrossRef
15.
Zurück zum Zitat Sheen YH et al (2018) Association of asthma with rheumatoid arthritis: a population-based case-control study. J Allergy Clin Immunol Pract 6(1):219–226CrossRef Sheen YH et al (2018) Association of asthma with rheumatoid arthritis: a population-based case-control study. J Allergy Clin Immunol Pract 6(1):219–226CrossRef
16.
Zurück zum Zitat Hemminki K et al (2010) Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care? Ann Epidemiol 20(3):217–222CrossRef Hemminki K et al (2010) Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care? Ann Epidemiol 20(3):217–222CrossRef
17.
Zurück zum Zitat Krishna MT et al (2019) Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. Eur Respir J 54(5):1900476CrossRef Krishna MT et al (2019) Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. Eur Respir J 54(5):1900476CrossRef
18.
Zurück zum Zitat Murai H et al (2004) High frequency of allergic conjunctivitis in myasthenia gravis without thymoma. J Neurol Sci 225(1–2):27–31CrossRef Murai H et al (2004) High frequency of allergic conjunctivitis in myasthenia gravis without thymoma. J Neurol Sci 225(1–2):27–31CrossRef
19.
Zurück zum Zitat Tsai JD et al (2014) Increased subsequent risk of myasthenia gravis in children with allergic diseases. J Neuroimmunol 276(1–2):202–206CrossRef Tsai JD et al (2014) Increased subsequent risk of myasthenia gravis in children with allergic diseases. J Neuroimmunol 276(1–2):202–206CrossRef
20.
Zurück zum Zitat Yeh JH et al (2015) Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study. Medicine 94(21):e835CrossRef Yeh JH et al (2015) Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study. Medicine 94(21):e835CrossRef
21.
Zurück zum Zitat Gong P-H et al (2017) Acute severe asthma with thyroid crisis and myasthenia: a case report and literature review. Clin Respir J 11(6):671–676CrossRef Gong P-H et al (2017) Acute severe asthma with thyroid crisis and myasthenia: a case report and literature review. Clin Respir J 11(6):671–676CrossRef
23.
Zurück zum Zitat Souza-Machado A, Ponte E, Cruz AA (2007) Severe asthma associated with myasthenia gravis and upper airway obstruction. J Investig Allergol Clin Immunol 17(4):267–270PubMed Souza-Machado A, Ponte E, Cruz AA (2007) Severe asthma associated with myasthenia gravis and upper airway obstruction. J Investig Allergol Clin Immunol 17(4):267–270PubMed
24.
Zurück zum Zitat Wells GA et al (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford Wells GA et al (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford
25.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRef
26.
Zurück zum Zitat Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRef Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRef
27.
Zurück zum Zitat Murai H et al (1997) Expression of CD23 in the germinal center of thymus from myasthenia gravis patients. J Neuroimmunol 76(1–2):61–69CrossRef Murai H et al (1997) Expression of CD23 in the germinal center of thymus from myasthenia gravis patients. J Neuroimmunol 76(1–2):61–69CrossRef
28.
Zurück zum Zitat Bansal AS et al (1993) Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 79(2):285–289PubMedPubMedCentral Bansal AS et al (1993) Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 79(2):285–289PubMedPubMedCentral
29.
Zurück zum Zitat Gordon J (1992) CD23 and B cell activation. Clin Exp Allergy 22(2):199–204CrossRef Gordon J (1992) CD23 and B cell activation. Clin Exp Allergy 22(2):199–204CrossRef
30.
Zurück zum Zitat Balbino B et al (2018) Approaches to target IgE antibodies in allergic diseases. Pharmacol Ther 191:50–64CrossRef Balbino B et al (2018) Approaches to target IgE antibodies in allergic diseases. Pharmacol Ther 191:50–64CrossRef
31.
Zurück zum Zitat Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18(5):693–704CrossRef Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18(5):693–704CrossRef
32.
Zurück zum Zitat Robinson DS (2010) The role of the T cell in asthma. J Allergy Clin Immunol 126(6):1081–1091CrossRef Robinson DS (2010) The role of the T cell in asthma. J Allergy Clin Immunol 126(6):1081–1091CrossRef
33.
Zurück zum Zitat Zhong H, Zhao C, Luo S (2019) HLA in myasthenia gravis: from superficial correlation to underlying mechanism. Autoimmun Rev 18(9):102349CrossRef Zhong H, Zhao C, Luo S (2019) HLA in myasthenia gravis: from superficial correlation to underlying mechanism. Autoimmun Rev 18(9):102349CrossRef
34.
Zurück zum Zitat Muñiz-Castrillo S, Vogrig A, Honnorat J (2020) Associations between HLA and autoimmune neurological diseases with autoantibodies. Auto Immun Highlights 11(1):2CrossRef Muñiz-Castrillo S, Vogrig A, Honnorat J (2020) Associations between HLA and autoimmune neurological diseases with autoantibodies. Auto Immun Highlights 11(1):2CrossRef
35.
Zurück zum Zitat Schoettler N et al (2019) Advances in asthma and allergic disease genetics: Is bigger always better? J Allergy Clin Immunol 144(6):1495–1506CrossRef Schoettler N et al (2019) Advances in asthma and allergic disease genetics: Is bigger always better? J Allergy Clin Immunol 144(6):1495–1506CrossRef
36.
Zurück zum Zitat Shiina T, Inoko H, Kulski JK (2004) An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64(6):631–649CrossRef Shiina T, Inoko H, Kulski JK (2004) An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64(6):631–649CrossRef
37.
Zurück zum Zitat Kontakioti E et al (2014) HLA and asthma phenotypes/endotypes: a review. Hum Immunol 75(8):930–939CrossRef Kontakioti E et al (2014) HLA and asthma phenotypes/endotypes: a review. Hum Immunol 75(8):930–939CrossRef
38.
Zurück zum Zitat Kang SW et al (2019) Promoter polymorphism (− 308G/A) of tumor necrosis factor-alpha (TNF-α) gene and asthma risk: an updated meta-analysis. Genet Test Mol Biomark 23(6):363–372CrossRef Kang SW et al (2019) Promoter polymorphism (− 308G/A) of tumor necrosis factor-alpha (TNF-α) gene and asthma risk: an updated meta-analysis. Genet Test Mol Biomark 23(6):363–372CrossRef
39.
Zurück zum Zitat Sun H et al (2018) Associations of tumor necrosis factor-α polymorphisms with the risk of asthma: a meta-analysis. Exp Mol Pathol 105(3):411–416CrossRef Sun H et al (2018) Associations of tumor necrosis factor-α polymorphisms with the risk of asthma: a meta-analysis. Exp Mol Pathol 105(3):411–416CrossRef
40.
Zurück zum Zitat Mikhail I, Grayson MH (2019) Asthma and viral infections: an intricate relationship. Ann Allergy Asthma Immunol 123(4):352–358CrossRef Mikhail I, Grayson MH (2019) Asthma and viral infections: an intricate relationship. Ann Allergy Asthma Immunol 123(4):352–358CrossRef
41.
Zurück zum Zitat Le Panse R, Berrih-Aknin S (2013) Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation. Curr Opin Neurol 26(5):569–576CrossRef Le Panse R, Berrih-Aknin S (2013) Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation. Curr Opin Neurol 26(5):569–576CrossRef
42.
Zurück zum Zitat Gilhus NE et al (2018) Myasthenia gravis and infectious disease. J Neurol 265(6):1251–1258CrossRef Gilhus NE et al (2018) Myasthenia gravis and infectious disease. J Neurol 265(6):1251–1258CrossRef
Metadaten
Titel
The Association Between Asthma and Risk of Myasthenia Gravis: A Systematic Review and Meta-analysis
verfasst von
Pitchaporn Yingchoncharoen
Nipith Charoenngam
Ben Ponvilawan
Jerapas Thongpiya
Thanat Chaikijurajai
Patompong Ungprasert
Publikationsdatum
13.05.2021
Verlag
Springer US
Erschienen in
Lung / Ausgabe 3/2021
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-021-00444-8

Weitere Artikel der Ausgabe 3/2021

Lung 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.